Valuation: Beijing Beilu Pharmaceutical Co., Ltd.

Market Cap 4.65B 684M 599M 552M 512M 973M 65.25B 986M 6.61B 2.57B 32.03B 2.57B 2.51B 111B P/E 2024
207x
P/E 2025 44.1x
Enterprise Value 4.48B 659M 577M 532M 494M 937M 62.88B 950M 6.37B 2.48B 30.87B 2.48B 2.42B 107B EV / Sales 2024
3.29x
EV / Sales 2025 3.57x
Free-Float
56.4%
Yield 2024
0.81%
Yield 2025 -
1 day+0.72%
1 week+6.50%
Current month+9.00%
1 month+5.29%
3 months-16.57%
6 months-8.73%
Current year+5.29%
1 week 7.64
Extreme 7.64
8.57
1 month 7.08
Extreme 7.08
8.57
Current year 7.08
Extreme 7.08
11.38
1 year 7.08
Extreme 7.08
11.98
3 years 3.58
Extreme 3.58
11.98
5 years 3.58
Extreme 3.58
11.98
10 years 3.58
Extreme 3.58
15.85
Manager TitleAgeSince
Chief Executive Officer 42 11/12/2017
Director of Finance/CFO 34 01/08/2019
Chief Operating Officer 45 25/08/2022
Director TitleAgeSince
Chairman 42 01/08/2019
Chairman 48 21/03/2019
Director/Board Member 46 21/03/2019
Date Insider Type Main position Quantity % Market Cap.
14/09/21Sell

Executive/Senior Manager

10,000 0.0025%
10/09/21Sell

Executive/Senior Manager

77,000 0.0189%
09/06/21Sell

Executive/Senior Manager

60,000 0.0150%
Change 5-day change 1-year change 3-year change Capi.($)
+0.72%+6.50%-16.48%+25.71% 716M
+2.98%+3.25%+60.23%+173.93% 1,070B
+3.75%+5.78%+73.02%+68.70% 624B
+1.14%+2.53%+37.50%+90.40% 450B
+2.02%-2.07%+27.62%+22.57% 328B
+2.21%+2.16%+40.97%+42.47% 292B
+1.48%+0.08%+29.78%+49.19% 284B
+2.09%+4.15%-25.74%-38.99% 217B
+1.14%+2.46%+26.65%+69.69% 198B
+4.40%+6.55%+20.43%+80.89% 161B
Average +2.17%+1.78%+27.40%+58.46% 362.51B
Weighted average by Cap. +2.46%+0.70%+43.96%+88.78%

Financials

2024 2025
Net sales 984M 145M 127M 117M 108M 206M 13.81B 209M 1.4B 544M 6.78B 544M 532M 23.5B 1.21B 177M 155M 143M 133M 252M 16.92B 256M 1.71B 667M 8.31B 666M 652M 28.8B
Net income 13.65M 2.01M 1.76M 1.62M 1.5M 2.86M 192M 2.9M 19.4M 7.55M 94.08M 7.55M 7.38M 326M 92.73M 13.65M 11.95M 11.01M 10.22M 19.41M 1.3B 19.67M 132M 51.29M 639M 51.26M 50.13M 2.22B
Net Debt 189M 27.83M 24.37M 22.45M 20.84M 39.57M 2.65B 40.11M 269M 105M 1.3B 105M 102M 4.52B -169M -24.85M -21.76M -20.04M -18.6M -35.33M -2.37B -35.81M -240M -93.37M -1.16B -93.31M -91.26M -4.03B
Logo Beijing Beilu Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production and sales of chemical drugs (including active pharmaceutical ingredients) and traditional Chinese medicine. The chemical drug business mainly focuses on the research, development, production and sales of contrast agents, hypoglycemic drugs and other products. The traditional Chinese medicine segment mainly focuses on the production and sales of central nervous system, heat-clearing and detoxifying, and tonic products. The Company's main products include gadopentetate dimeglumine injection, iohexol injection, repaglinide tablets, iohexol active pharmaceutical ingredient, Jiuwei Zhenxin Granules, Jinlianhua Granules, Qingwei Huanglian Pills and others. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
1,188
Date Price Change Volume
07/07/26 CN¥7.990 -4.43% 20,405,690
06/07/26 CN¥8.360 +0.72% 30,274,800
03/07/26 CN¥8.300 +1.47% 21,781,818
02/07/26 CN¥8.180 -0.73% 30,346,238
01/07/26 CN¥8.240 +7.43% 38,713,870

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300016 Stock